Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age
DRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 14. 2020 S. 2149-2158
Erscheinungsjahr: 2020
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Parini, Rossella (Autor)
Pintos-Morell, Guillem (Autor)
Hennermann, Julia B. (Autor)
Hsu, Ting-Rong (Autor)
Karabul, Nesrin (Autor)
Kalampoki, Vasiliki (Autor)
Gurevich, Andrey (Autor)
Ramaswami, Uma (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
